| Home |
|
||||||||||||||||
|
|
Management |
||||||||||||||||
|
|
Kevin FitzGerald Prior to joining f-star, Dr Kevin FitzGerald was CEO and a main board member of Isogenica Ltd. which he founded in 2000. Before establishing Isogenica, Kevin was a member of the senior management team at Actinova Ltd., the UK subsidiary of Active Biotech AB. Prior to this Kevin spent seven years at Cambridge Antibody Technology plc. (acquired by AstraZeneca in 2006) where he was among the founding group of scientists.
Kevin studied for his PhD in the laboratory of Sir Greg Winter FRS at
the MRC Laboratory of Molecular Biology, Cambridge and for his MBA at
Aston Business School following receipt of a Sainsbury Management
Fellowship from the Royal Academy of Engineering, London. Kevin was
elected a fellow of the Royal Society of Medicine in 2006. |
|
|||||||||||||||
| |
©2007 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H., all rights reserved
|
||||||||||||||||